Cargando…

Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI

INTRODUCTION: Age, polycystic ovary syndrome (PCOS), low body mass index (BMI), high antral follicle count (AFC), increased anti-Muller hormone (AMH) levels, and elevated serum estradiol (E2) concentrations are risk factors for ovarian hyperstimulation syndrome (OHSS). However, data on the relations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Bo, Ma, Yujia, Li, Lu, Hu, Linli, Wang, Fang, Zhang, Yile, Dai, Shanjun, Sun, Yingpu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851086/ https://www.ncbi.nlm.nih.gov/pubmed/33542709 http://dx.doi.org/10.3389/fendo.2020.615957

Ejemplares similares

The Relationship Between Serum Delta FSH Level and Ovarian Response in IVF/ICSI Cycles
por: Hu, Linli, et al.
Publicado: (2020)

The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
por: Zhu, Xiuxian, et al.
Publicado: (2016)

Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
por: Lappas, V, et al.
Publicado: (1999)

Prediction of ovarian hyperstimulation syndrome in coasted patients in an IVF/ICSI program
por: Aljawoan, Fatimah Y, et al.
Publicado: (2012)

Nomogram Model to Predict the Probability of Ovarian Hyperstimulation Syndrome in the Treatment of Patients With Polycystic Ovary Syndrome
por: Li, Fei, et al.
Publicado: (2021)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2015)

Risk of Higher Blood Pressure in 3 to 6 Years Old Singleton Born From OHSS Patients Undergone With Fresh IVF/ICSI
por: Zhu, Yimin, et al.
Publicado: (2022)

Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy
por: Di Guardo, Federica, et al.
Publicado: (2023)

Effect and Relationship of Seasons on the High Risk of Ovarian Hyperstimulation Syndrome After Oocyte Retrieval in Patients With Polycystic Ovary Syndrome
por: Cao, Yurong, et al.
Publicado: (2021)

Ovarian Hyperstimulation Syndrome (OHSS) requiring Intensive Care Unit (ICU) admission between 1996-2020 in England, Wales, and Northern Ireland
por: Abbara, Ali, et al.
Publicado: (2022)

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment
por: Fiedler, Klaus, et al.
Publicado: (2012)

Outpatient Management of Severe Ovarian Hyperstimulation Syndrome (OHSS) with Placement of Pigtail Catheter
por: Abuzeid, M., et al.
Publicado: (2014)

Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)
por: Farkas, Balint, et al.
Publicado: (2020)

Comparative Effectiveness of Three Ovarian Hyperstimulation Protocol in In Vitro Fertilization (IVF) Cycles for Women with Polycystic Ovary Syndrome
por: Chen, Yilu, et al.
Publicado: (2018)

A Slower Age-Related Decline in Treatment Outcomes After the First Ovarian Stimulation for in vitro Fertilization in Women With Polycystic Ovary Syndrome
por: Li, Jing, et al.
Publicado: (2019)

Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
por: Xing, Weijie, et al.
Publicado: (2015)

Melatonin Ameliorates Ovarian Hyperstimulation Syndrome (OHSS) through SESN2 Regulated Antiapoptosis
por: Zheng, Min, et al.
Publicado: (2023)

Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI
por: Dielen, C, et al.
Publicado: (2017)

Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy
por: Abbara, Ali, et al.
Publicado: (2015)

Serum GDF-8 levels change dynamically during controlled ovarian hyperstimulation in patients undergoing IVF/ICSI-ET
por: Fang, Lanlan, et al.
Publicado: (2016)

Patients with IVF complicated by moderate-to-critical OHSS experience increased thrombosis, GDM and neonatal NICU admission but slightly shorter gestation compared with matched IVF counterparts: A retrospective Chinese cohort study
por: Hu, Linli, et al.
Publicado: (2021)

Efficacy of dehydroepiandrosterone priming in women with poor ovarian response undergoing IVF/ICSI: a meta-analysis
por: Zhang, Jie, et al.
Publicado: (2023)

The role of serum vitamin D in patients with normal ovarian reserve undergoing the first IVF/ICSI cycle
por: Luo, Rong, et al.
Publicado: (2023)

Erratum to: Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2016)

The homeostasis model assessment of insulin resistance is a judgment criterion for metformin pre-treatment before IVF/ICSI and embryo transfer cycles in patients with polycystic ovarian syndrome
por: Gao, Rui, et al.
Publicado: (2023)

The Effect of Sperm DNA Fragmentation on In Vitro Fertilization Outcomes for Women With Polycystic Ovary Syndrome
por: Wang, Huan, et al.
Publicado: (2022)

Letrozole cotreatment improves the follicular output rate in high-body-mass-index women with polycystic ovary syndrome undergoing IVF treatment
por: Liu, Yali, et al.
Publicado: (2023)

Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
por: Peng, Qingjie, et al.
Publicado: (2023)

Effect of BMI on the value of serum progesterone to predict clinical pregnancy outcome in IVF/ICSI cycles: a retrospective cohort study
por: Shen, Zhaoyang, et al.
Publicado: (2023)

Persistent megalocystic ovaries after ovarian hyperstimulation syndrome in a postpartum patient with polycystic ovarian syndrome: a case report
por: Shi, Jinghua, et al.
Publicado: (2018)

Follicular-Phase GnRH Agonist Protocol Is Another Choice for Polycystic Ovary Syndrome Patients With Lower LH/FSH and Lower AMH Levels Without Increasing Severe OHSS Risk
por: Gao, Rui, et al.
Publicado: (2022)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)—a retrospective case–control study
por: Nouri, Kazem, et al.
Publicado: (2014)

Nintedanib Treatment After Ovulation is an Effective Therapeutic Strategy for the Alleviation of Ovarian Hyperstimulation Syndrome (OHSS) in a Mouse Model
por: Jiang, Shutian, et al.
Publicado: (2022)

Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment
por: Liu, Yali, et al.
Publicado: (2022)

Impact of Insulin Resistance on Ovarian Sensitivity and Pregnancy Outcomes in Patients with Polycystic Ovary Syndrome Undergoing IVF
por: Luo, Zhuoye, et al.
Publicado: (2023)

The clinical value of progestin-primed ovarian stimulation protocol for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis
por: Lin, Guangyao, et al.
Publicado: (2023)

Association between Body Mass Index and Reproductive Outcome in Women with Polycystic Ovary Syndrome Receiving IVF/ICSI-ET
por: Zhou, Han, et al.
Publicado: (2020)

Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation
por: Huang, Ying, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_eb9jdqjsldiuo43apn0sr63271